Clindamycin-13C,D3 Hydrochloride

• CAT Number: C000391
• CAS Number: 2140264-64-6
• Molecular Formula: C₁₇¹³CH₃₀D₃ClN₂O₅S • HCl
• Molecular Weight: 465.51
• Purity: ≥95%
• Synonyms: Methyl 7-Chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-13C,D3-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside Hydrochloride; trans-α-Methyl 7-Chloro-6,7,8-trideoxy-6-(1-methyl-13C,D3-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-D-galacto-octopyranoside Hydrochloride; (2S-trans)-Methyl 7-Chloro-6,7,8-trideoxy-6-[[(1-methyl-13C,D3-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside Hydrochloride; 7(S)-Chloro-7-deoxylincomycin-13C,D3 Hydrochloride; 7-CDL-13C,D3 Hydrochloride; 7-Chloro-7-deoxylincomycin-13C,D3 Hydrochloride; 7-Chlorolincomycin-13C,D3 Hydrochloride; 7-Deoxy-7(S)-chlorolincomycin-13C,D3 Hydrochloride; Antirobe-13C,D3 Hydrochloride; Chlolincocin-13C,D3 Hydrochloride; Cleocin-13C,D3 Hydrochloride; Clincin-13C,D3
• Solubility: Methanol (Very Slightly, Heated), Water (Slightly)
• Appearance: White Solid
• Storage: -20°C, Hygroscopic
• IUPAC Name: (2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-4-propyl-1-(trideuterio(113C)methyl)pyrrolidine-2-carboxamide;hydrochloride
• InChI: InChI=1S/C18H33ClN2O5S.ClH/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4;/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25);1H/t9-,10+,11-,12+,13-,14+,15+,16+,18+;/m0./s1/i3+1D3
• InChIKey: AUODDLQVRAJAJM-QBUBXJGKSA-N
• SMILES: [2H][13C]([2H])([2H])N1C[C@@H](C[C@H]1C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl)CCC.Cl

Clindamycin-13C,D3 Hydrochloride(CAT: C000391) is an isotopically labeled derivative of clindamycin, a widely used antibiotic with activity against Gram-positive and anaerobic bacteria. This labeled compound incorporates three deuterium (D3) and carbon-13 isotopes, making it invaluable for pharmacokinetic, metabolic, and analytical studies using mass spectrometry. It retains the antimicrobial properties of clindamycin, providing researchers with a reliable tool for tracking drug distribution, metabolism, and interactions in complex biological systems. Clindamycin-13C,D3 Hydrochloride is particularly useful for studying antibiotic mechanisms, resistance pathways, and optimizing therapeutic dosing regimens in pharmaceutical development.

Reference

Birkenmeyer, R.D., et al.: J. Med. Chem., 13, 616 (1970); Oesterling, et al.: J. Pharm. Sci., 59, 63 (1970); Gray, J.E., et al.: Toxicol. Appl. Pharmacol., 21, 516 (1972); Brown, L.W., et al.: Anal. Profiles Drug Subs., 10, 75 (1981)